Skip to content
Catalyst

Lacticaseibacillus rhamnosusFinding

Lacticaseibacillus rhamnosus increases stool frequency

raisesModerate evidenceFinding

01 · The sentence it was drawn from

“The defecation frequency was significantly higher in the L. rhamnosus JYLR-127-administered TRE group compared to the pre-intervention FAC group and the placebo-controlled CDN group (FAC vs. CDN vs. TRE = 2.24 ± 0.72 vs. 2.06 ± 0.70 vs. 3.04 ± 1.54, p < 0.001), with Bristol scoring closer to the median value of 3.50 (FAC vs. CDN vs. TRE = 3.16 ± 0.99 vs. 2.99 ± 0.82 vs. 3.63 ± 0.95, p < 0.01, Figure 2A).”
Quoted verbatim from Improvement of Post-Surgery Constipation in Patients with Fractures by Lactobacillus rhamnosus JYLR-127: A Single-Blind Randomized Controlled Trial.
This finding among the 8 findings on its endpoint

Lacticaseibacillus rhamnosus

Stool frequency

raises

Who
Fracture patients with post-surgery constipation (CSS >= 6, Bristol < 3); TRE probiotic arm versus placebo CDN arm after one week; a pre-intervention FAC group is also compared; p is a three-group ANOVA
Dose studied
4 g/day, twice daily, 2 g per dose, one week

Moderate evidencePMID 38794748 · 2024

02 · The study

Study
RCT
Duration
7 days

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7G6G8ESKHHKB9BSSBB4F4BV